General Information


Our differentiated, physics-based software platform enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly, at lower cost, and with, we believe, a higher likelihood of success compared to traditional methods. Our software is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world, and we are the leading provider of computational software solutions for drug discovery. We also apply our computational platform to a broad pipeline of drug discovery programs in collaboration with biopharmaceutical companies, some of which we co-founded. In addition, we are using our platform to advance a pipeline of internal, wholly-owned drug discovery programs.

Employees: 392
Founded: 1990
Contact Information
Address 120 West 45th Street, 17th Floor, New York, NY 10036, US
Phone Number (212) 295-5800
Web Address
View Prospectus: Schrodinger
Financial Information
Market Cap $1044.6mil
Revenues $77.2 mil (last 12 months)
Net Income $-24.2 mil (last 12 months)
IPO Profile
Symbol SDGR
Exchange NASDAQ
Shares (millions): 11.9
Price range $17.00 - $17.00
Est. $ Volume $202.0 mil
Manager / Joint Managers Morgan Stanley/ BofA Securities/ Jefferies/ BMO Capital Markets
CO-Managers -
Expected To Trade: 2/6/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change